AGEN logo

Agenus (AGEN) Company Overview

Profile

Full Name:

Agenus Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 8, 2000

Indexes:

Not included

Description:

Agenus is a biotechnology company focused on developing innovative immunotherapies for cancer treatment. They create therapies that help the immune system recognize and attack cancer cells, aiming to improve patient outcomes and advance cancer care through research and clinical trials.

Key Details

Price

$3.29

Annual Revenue

$156.31 M(+59.47% YoY)

Annual EPS

-$13.80(+11.54% YoY)

Annual ROE

153.28%

Beta

2.87

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 12, 2024

Analyst ratings

Recent major analysts updates

Jan 22, 25 HC Wainwright & Co.
Neutral
Dec 5, 24 HC Wainwright & Co.
Neutral
Nov 29, 24 HC Wainwright & Co.
Neutral
Nov 12, 24 HC Wainwright & Co.
Neutral
Aug 14, 24 B. Riley Securities
Buy
Jul 19, 24 Jefferies
Hold
Jul 18, 24 HC Wainwright & Co.
Neutral
Jun 28, 24 HC Wainwright & Co.
Buy
May 24, 24 HC Wainwright & Co.
Buy
May 7, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Agenus?
  • Does Agenus pay dividends?
  • What sector is Agenus in?
  • What industry is Agenus in?
  • What country is Agenus based in?
  • When did Agenus go public?
  • Is Agenus in the S&P 500?
  • Is Agenus in the NASDAQ 100?
  • Is Agenus in the Dow Jones?
  • When was Agenus's last earnings report?
  • When does Agenus report earnings?
  • Should I buy Agenus stock now?

What is the ticker symbol for Agenus?

The ticker symbol for Agenus is NASDAQ:AGEN

Does Agenus pay dividends?

No, Agenus does not pay dividends

What sector is Agenus in?

Agenus is in the Healthcare sector

What industry is Agenus in?

Agenus is in the Biotechnology industry

What country is Agenus based in?

Agenus is headquartered in United States

When did Agenus go public?

Agenus's initial public offering (IPO) was on February 8, 2000

Is Agenus in the S&P 500?

No, Agenus is not included in the S&P 500 index

Is Agenus in the NASDAQ 100?

No, Agenus is not included in the NASDAQ 100 index

Is Agenus in the Dow Jones?

No, Agenus is not included in the Dow Jones index

When was Agenus's last earnings report?

Agenus's most recent earnings report was on Nov 12, 2024

When does Agenus report earnings?

The next expected earnings date for Agenus is Mar 14, 2025

Should I buy Agenus stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions